We found that the TREM2 R47H AD risk variants are associated with a shift in microglial phenotype from ARM to motile, and that the ARM and motile microglia appear to represent distinct activation phenotypes emanating from homeostatic microglia. This evidence concerns the gene TREM2 and Alzheimer disease.